Deferasirox 360 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FY1G7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,655
Award facts
- Contract value 100% obligated
- $28,655.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $28,655.27 and an ultimate completion date of October 28, 2025. The contract involves no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive pharmaceutical supply mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capabilities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a prime contractor under the DLA Troop Support Medical indefinite delivery contract, AmerisourceBergen is positioned to supply pharmaceutical products and medical commodities to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Deferasirox, an iron chelation therapy medication, represents a routine execution of the company's ongoing pharmaceutical supply obligations.
Quick answers
Who was awarded contract SPE2DB26FY1G7?
SPE2DB26FY1G7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FY1G7 worth?
The government has obligated $28,655 on SPE2DB26FY1G7.
Is contract SPE2DB26FY1G7 an order under another contract?
Yes. SPE2DB26FY1G7 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1G7 competed?
The extent of competition for SPE2DB26FY1G7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award